Safety evaluation of a recombinant myxoma-RHDV virus inducing horizontal transmissible protection against myxomatosis and rabbit haemorrhagic disease.
Torres JM, Ramírez MA, Morales M, Bárcena J, Vázquez B, Espuña E, Pagès-Manté A, Sánchez-Vizcaíno JM.
Torres JM, et al. Among authors: barcena j.
Vaccine. 2000 Sep 15;19(2-3):174-82. doi: 10.1016/s0264-410x(00)00183-3.
Vaccine. 2000.
PMID: 10930670
Free PMC article.
We have recently developed a transmissible vaccine to immunize rabbits against myxomatosis and rabbit haemorrhagic disease based on a recombinant myxoma virus (MV) expressing the rabbit haemorrhagic disease virus (RHDV) capsid protein [Barcena et al. Horizontal transmissib …
We have recently developed a transmissible vaccine to immunize rabbits against myxomatosis and rabbit haemorrhagic disease based on a recomb …